Effects of antioxidants on vascular health
|
|
- Oliver Taylor
- 6 years ago
- Views:
Transcription
1 Effects of antioxidants on vascular health Garry G Duthie and Mary C Bellizzi Rowett Research Institute, Aberdeen, UK Substantial in vitro and animal model evidence implicates the free radicalmediated oxidation of low density lipoprotein and its subsequent preferential uptake by macrophages in the arterial intima as an important factor in the development of vascular disease. In addition, antioxidants which prevent the oxidation of LDL in vitro also reduce the severity of vascular disease in animal models. Although some epidemiological studies also suggest that inadequate antioxidant status is related to the development of vascular disease, particularly cardiovascular disease, results from intervention trials have been contradictory. Whereas vitamin E may have a role in reducing the incidence of vascular disease, evidence is less strong for vitamin C, flavonoids and (J-carotene. Additionally, supplementation with some antioxidants such as p-carotene may increase the incidence of cancer in high risk groups. Although increasing antioxidant intake is generally beneficial for health, this should perhaps be achieved by an increased dietary intake of antioxidant-rich foods rather than by use of supplements. Correspondence to: Dr Garry G Duthie, Rowett Research Institute, Greenburn Road, Bucksburn, Aberdeen AB25 95B, UK There is strong evidence that diets rich in fruit and vegetables protect against the development of vascular disease 1. This has been attributed, in part, to the antioxidants in such foods inhibiting cellular damage by free radicals. These are potentially reactive molecules with an unpaired electron which can confer considerable chemical reactivity on the molecule 2. Reactive oxygen species are formed endogenously during the stepwise reduction of oxygen to water and by secondary reactions with protons and transition metals such as copper and iron. For example, the superoxide anion is produced in many cell redox systems such as those involving xanthine oxidase, aldehyde oxidase, membrane-associated NADPH oxidases and the cytochrome P450 system. In addition, cells are exposed to radicals arising from cigarette smoke, pollution, UV light, ionising radiation, ultra-sound and mechanical shearing forces. Many of these free radicals have the potential to interact with biological molecules such as proteins, lipids and DNA and there is now substantial evidence that they are involved in the aetiology of many diseases including vascular disease 3. Antioxidants which prevent free radical reactions may, therefore, play an important role in modifying the development of such diseases. Living British Medical Bulletin 1999, 55 (No. 3): The British Council 1999
2 Antioxidants and vascular disease organisms have evolved complex antioxidant defence systems to minimise the damaging effects of excessive exposure to endogenously and exogenously produced free radicals. Biological antioxidants are, therefore, defined 4 as 'compounds that protect biological systems against the potentially harmful effects of processes or reactions that can cause excessive oxidations' and are generally characterised by being readily absorbed, transported to the relevant site within the cell for optimum function and relatively non-toxic at nutritionally-relevant intakes. They inhibit the oxidation of cellular components by directly scavenging reactive oxygen and nitrogen species, by metabolising lipid peroxides to non-radical products and by the chelation of metal ions to prevent generation of oxidising species. The main antioxidant micronutrients of dietary origin are vitamins E and C, the carotenoids and polyphenols. Vitamin E (in particular d-atocopherol) is a phenolic that is probably the main lipid-soluble antioxidant in human tissues. It is an example of a chain-breaking type antioxidant. Vitamin C is water-soluble and efficiently scavenges a range of reactive oxygen species such as the superoxide anion, hydroxyl radicals, peroxyl radicals and singlet oxygen. It can also chelate trace elements such as Fe and Cu thus inhibiting the catalytic decomposition of hydroperoxides to potentially damaging products. Carotenoids are polyisoprenoid structures with an extensive conjugated double bond system. Although many carotenoids may have antioxidant function, most attention has been directed towards [3-carotene which is particularly effective at scavenging singlet oxygen. It is also an effective antioxidant at low partial pressures of oxygen under conditions where singlet oxygen is not formed and, therefore, may be important at the physiological oxygen tensions in tissues. Polyphenolic products of the plant phenylpropanoid biosynthetic pathway such as the flavonoids were originally regarded as being nutritionally inert, but there is now increasing interest in their potential antioxidant properties. In addition, a number of enzymes with antioxidant function require trace elements from the diet as cofactors. Cytoplasmic and mitochondrial superoxide dismutases (EC ) require copper, zinc and manganese to catalyse the removal of superoxide radicals. Hydrogen peroxide in the cell is removed by catalase (EC ) which requires iron and also by cytosolic glutathione peroxidase (EC ). Several varieties of this latter enzyme also remove potentially toxic lipid hydroperoxides from the cell and are dependent on selenium for optimum function. There are also many other natural and synthetic products which have potential antioxidant activity. Detailed reviews of the structures, functions and mechanisms of antioxidants are readily available 5. If the antioxidant defence system is compromised, damage to biological molecules may occur and lead to the initiation and propagation of the British Medical Bulletin 1999;5S (No. 3) 569
3 Micronutrients in health and disease underlying processes involved in the pathogenesis of many diseases. The aim of this article is to discuss the hypothesis that the free radicalmediated oxidation of low density lipoprotein (LDL) is a key event in the development of vascular disease and the therapeutic benefits of intervention with antioxidant nutrients. Oxidation of low density lipoprotein Considerable in vitro evidence implicates the oxidation of low density lipoprotein (LDL) in atherogenesis. In brief, LDL is a heterogeneous structure containing phospholipids, free and esterified cholesterol, triglycerides, and amino acids which form apolipoprotein B (apob). The proteins and the polyunsaturated fatty acid components of the LDL are susceptible to free radical-mediated oxidation, particularly if the antioxidant content of the LDL is low. When LDL is oxidised in vitro, there is a loss of polyunsaturated fatty acids to yield a range of fragments of 3-9 carbon lengths including hydroperoxides, aldehydes and ketones which conjugate with other LDL-bound lipids and the apob 6. In cell cultures, this 'minimally-modified' LDL has a number of properties that could increase its atherogenicity. It is recognised by at least three types of scavenger receptors in macrophages which rapidly internalise the oxidised LDL. The macrophages are transformed into 'foam-like cells' which, in vivo, are regarded as precursors to the development of the occlusive plaque 7. In addition, oxidised LDL stimulates the release of macrophage colony stimulating factor and monocyte chemoattractant protein 1 from cells 8. Such observations have lead to the proposal that, in vivo, LDL in arterial endothehal cells may be oxidised by cellular enzymes such as NADPH oxidase, myeloperoxidase, lipoxygenase or by the leakage of free radicals from the mitochondrial electron transport chain. The presence of minimally-modified LDL induces the surrounding vascular cells to produce the chemoattractants and stimulating factors that cause monocytic accumulation and their subsequent differentiation to macrophages. On transformation of monocytes to macrophages, the oxidised LDL limits further macrophage mobility and decreases their ability to migrate away from the artery wall. The enhanced rate of uptake of oxidised LDL by the macrophages via the scavenger receptor pathways may then convert them into foam cells. In addition, since the macrophage can oxidatively modify native LDL via the respiratory burst, autocatalytic progression may lead to their continuous growth to form the plaque that begins to occlude the artery. These proposed events have not as yet been demonstrated in vivo. However, LDL extracted from human atherosclerotic lesions, but not normal arteries, appears to contain products of 570 British Medical Bulletin 1999,55 (No. 3)
4 Antioxidants and vascular disease lipid peroxidation such as F2-isoprostanes and malonaldehyde 9. Moreover, antibodies raised against oxidised LDL react with such lesions 1011 and elevated amounts of oxidised LDL are present in blood of patients with atherosclerotic disease 12. Therefore, it is plausible that oxidised LDL is involved in the atherosclerotic process although such observations do not necessarily imply a causal relationship between oxidised LDL and vascular disease. Intervention with antioxidants Animal studies Many in vitro studies have shown that the oxidation of LDL by endothelial cells, macrophages and Cu 2+ can be inhibited by the addition of synthetic and natural antioxidants 13. This suggests that antioxidants may play a role in limiting the progression of vascular disease. However, there is an important distinction between the in vitro antioxidant effectiveness of a substance and its ability to prevent the oxidation of LDL in vivo. The effectiveness of biological antioxidants in vivo is also dependent on their need to be readily absorbed, and transported and incorporated within the LDL for optimum function. Nevertheless, several animal models do suggest that increasing dietary intakes of some antioxidants can inhibit the progression of vascular disease. For example, the feeding of antioxidants such as vitamin E, probucol, butylhydroxytoluene and BO-653 increases the resistance of LDL to oxidation and reduces the lesions in arteries of rabbits, mice and monkeys which are either genetically-susceptible to vascular disease or have been fed atheroscleroticpromoting diets 14 ' 15. Human studies A number of clinical studies indicate that supplementation with antioxidants such as probucol, vitamin E and vitamin C (but not P-carotene) increases the resistance of LDL to oxidation ex vivo 16, although it is no.t clear in such short-term studies whether they also reduce the severity of atherosclerosis. Moreover, the few randomised, double blind, placebocontrolled trials with human volunteers aimed at answering this question (Table 1) have given inconsistent results. For example, the CHAOS study 17 involving 2000 men and women with angiographically defined coronary artery disease resulted in a marked reduction in nonfatal myocardial infarction in subjects taking vitamin E compared with the placebo group. In contrast, the ATBC study 18 with 29,000 male British Medial Bulletin 1999;55 (No. 3) 571
5 Micronutrients in health and disease Table 1 Summary of intervention trials with antioxidant supplements and vascular disease Authors Acronym Treatment Comments Stephens et ap 1 CHAOS 400 or 800 IU vitamin E/day or placebo in 2002 patients with diagnosed atherosclerosis A 47% decrease in cardiovascular related mortality and non fatal Ml after 200 days Rapola et ap ATBC 1862 male smokers with previous Ml history received daily, either 50 mg vitamin E, 20 mg P-carotene, both, or placebo over 5 years No significant differences among the 4 groups in total number of coronary events. Risk of non fatal Ml slightly lower in vitamin E group but fatal heart disease significantly lower in placebo group and 43% higher in p-carotene group Omenn eta/" CARET 18,314 smokers, ex-smokers and workers exposed to asbestos supplemented with 30 mg p-carotene + 25,100 IU vitamin A or placebo over 4 years Relative risk of death from cardiovascular disease 26% higher in supplemented group compared with placebo. Trial terminated early because also increased incidence of lung cancer in treatment group Hennekens et ap Physicians 22,071 healthy males allocated either Health 50 mg p-carotene or placebo for 12 years No significant differences in cardiovascular disease deaths, or incidence of Ml between the groups Abbreviations: CHAOS, Cambridge Heart Antioxidant Study; ATBC Alpha-Tocopherol Beta-Carotene Cancer Prevention Study; CARET, p-carotene and Retinol Efficacy Trial; IU, international unit; Ml, myocardial infarction. smokers found no effect of vitamin E on coronary artery events. Although this study was primarily aimed at investigating the effects of antioxidant supplements on the incidence of lung cancer, a subpopulation of 1862 male smokers with a history of myocardial infarction received daily in a double blind design 50 mg vitamin E, or 20 mg p-carotene or both micronutrients or a placebo. After a 5 year follow-up, there were no statistically significant differences among the 4 groups in the total number of major coronary events. However, adverse effect were apparent as the incidence of fatal heart disease was significantly lower in the placebo group and significantly higher (by 43%) in those given P-carotene. In addition, in the overall study, there were 18% more lung cancers and 8% greater mortality amongst subjects taking P-carotene compared with those on placebo. Similarly the Beta-Carotene and Retinol Efficacy Trial (CARET) 19 involving 18,000 smokers, former smokers and those who had been exposed to asbestos indicated that daily supplementation with 30 mg p-carotene and 25,000 IU of vitamin A increased the incidence of cardiovascular disease by 26% compared with the placebo group. This trial was terminated 21 months prematurely as, after 4 years, there were also 28% more lung cancers and 17% more deaths in the supplemented subjects compared with the placebo group. Such differences in outcome between intervention studies may reflect the range of doses used, the 572 British Medical Bulletin 1999;55 (No. 3)
6 Antioxidants and vascular disease duration of supplementation and the health status of the volunteers at the start of the study. For example, many antioxidants can also act as pro-oxidants under a range of circumstances and it is possible that unforeseen metabolic disturbances may occur after prolonged use of highly bio-available pure compounds; such effects may not be apparent when antioxidants are obtained from foods. Epidemiology Several epidemiological studies have suggested that low antioxidant status, as determined by analysis of plasma and tissue and by dietary assessment, is an important risk factor for the development of vascular disease (Table 2). Some large cohort studies indicated that a high intake of vitamin E, usually by self-supplementation, was associated with a significant reduction in cardiovascular disease as measured by various fatal and non-fatal endpoints. For example, the US Nurses Health Study 21, involving 87,000 females in a 8 year follow-up, concluded that those women taking 100 mg or more vitamin E/day for at least 2 years had a statistically significant reduction of relative risk ratio by 31% for myocardial infarction and cardiovascular mortality compared with women who did not use supplements. However, significant risk reductions were not observed for subjects taking supplements of vitamin C and p- carotene. Similarly, the Health Professionals Study 22, which included 39,000 men, did not find any clear associations between risk and vitamin C and (3-carotene intake. However, men in the upper quintile of vitamin E intake had a 40% reduction in relative risk ratio than those in the lower quintile after adjustment for potentially confounding factors such as age, smoking, body mass, calorie intake, fibre intake, alcohol intake, hypertension, aspirin use, family history and exercise. Paradoxically, vitamin E supplementation was not associated with changes in cardiovascular risk in a 7 year follow-up of 35,000 postmenopausal women 23, but there was a significant inverse association between vitamin E intake from food and incidence of cardiovascular disease. Some ecological studies have also revealed associations between intakes of antioxidants and cardiovascular disease (Table 2). For example, vitamin E intakes (in particular a-tocopherol) calculated from food supply data bases across 22 countries were strongly and inversely associated with mortality from cardiovascular disease 24. Similar significant associations were found across 7 countries in relation to the intake of flavonoids". However, other studies have failed to reveal any relationship between supply of nutritional antioxidants and disease (Table 2). Whether this reflects inappropriate study design and methodology or reflects a real lack of association between antioxidants British Medical Bulletin 1999;55 (No. 3) 573
7 Micronutrients in health and disease Table 2 Summary of epidemiological studies relating antioxidants to vascular disease Authors Type of study Comment Bellizzi et ap* Cross sectional Comparison of food and nutrient supply with CHD mortality in men across 24 countries between 1962 and Dietary vitamin E and vitamin C but not p-carotene significantly and negatively correlated with CVD mortality Riemersma et ap* Cross sectional Plasma vitamin E, vitamin C and selenium in men from Scotland, Finland and Southern Italy did not reflect regional CVD mortality rates Hertog et ap 5 Cross sectional Estimated intakes of flavonoids by FFQ across 7 countries significantly and negatively associated with incidence of CVD Gey 27 Cross sectional Plasma vitamin E and 'cumulative antioxidant index' comprising vitamin E, vitamin C, (^-carotene and selenium significantly and negatively associated with CVD mortality Rimm et ap 2 Prospective cohort Asymptomatic males followed for 4 years. Those on highest intakes of vitamin E (median 300 mg/day) as assessed by FFQ at lowest risk for CVD. No significant risk reduction for vitamin C and p-carotene Stampler et a/ 21 Prospective cohort Healthy female nurses followed up for 8 years. Those on highest intakes of vitamin E (median 150 mg/day) as assessed by FFQ at lowest risk for CVD. Significant risk reductions not observed for vitamin C or (}-carotene Hertog et ap* Prospective cohort Dietary intake of flavonoids significantly and negatively associated with CVD in 5 year follow-up of 805 males Knekt et ap* Prospective cohort Flavonoid intake associated with reduced risk of CVD in a 20 year follow up of 5113 subjects Hertog et ap Prospective cohort No relationship between dietary flavonoid intake estimated by FFQ and CVD mortality in 14 year follow-up of 1900 men Rimm et ap 2 Prospective cohort Re-analyses of Health Professional Study with a 6 year follow-up 34,789 males showed no clear relationship between flavonoid intake and CVD incidence Knekt et a/ 31 Prospective cohort A 14 year follow-up of Finnish men and women showed an inverse association between dietary vitamin E established from interview and CVD mortality Kushi et ap 3 Prospective cohort Postmenopausal women followed up for 12 years with the highest dietary intakes of vitamin E had lowest risk of CVD Losonczy et ap 2 Prospective cohort A CVD protective effect of vitamin E intakes > 70 mg/day found in a 9 year follow-up of elderly subjects. No effect of vitamin C Meyer etar 1 Prospective cohort In 2313 men followed over 7 years, vitamin supplement use, in particular vitamin E, was associated with a lower incidence and death from ischaemic heart disease Daviglus et a/ Prospective cohort Modest decrease in risk of stroke in highest quartile of intakes of fj-carotene and vitamin C in 1843 middle-aged men from the Chicago Western Electric Study Evans et a/ 33 Nested case control No significant association between serum (n = 734) concentrations of vitamin E or carotenoids with CVD risk or in fatal Ml Hense et ap 4 Nested case control No difference in serum vitamin E between controls and subjects with fatal and non-fatal coronary events Salonen et a/ 35 Nested case control No difference in serum vitamin E or selenium between subjects who had died of CVD and matched controls Duthie et a/ 3 * Case control No difference in Scottish men with stable angina and matched controls in plasma vitamin C, vitamin A and cholesterol-adjusted vitamin E Kardinaal et a/ 37 Case control Men from 10 European countries with first acute Ml did not have significantly different adipose tissue vitamin E compared with healthy controls Sklodowska et ap* Case control Plasma and red cell vitamin E of patients with unstable angina lower than in normal subjects Riemersma et a/ Case control Males with untreated angina had lower plasma vitamin E compared with controls Abbreviations: CVD, cardiovascular disease; FFQ, food frequency questionnaire; Ml, myocardial infarction. 574 British Medical Bulletin 1999;55 (No. 3)
8 Antioxidants and vascular disease and disease is still unclear. Some randomised trials may not have been specifically designed to assess cardiovascular disease. Others, such as nested case control studies, may have used archived blood samples in which there had been loss of antioxidants during storage. Moreover, plasma antioxidant concentrations, which were used as a measure of antioxidant status in some studies, may not necessarily reflect concentrations in target tissues such as the arterial intima where plaque development occurs. Conclusion There is very strong biochemical and animal model evidence that the oxidation of LDL is an important event in the development of vascular disease and that antioxidants which inhibit LDL oxidation can prevent or inhibit disease progression. However, this has not always been corroborated and indeed has even been contradicted by the results from epidemiological studies. Some intervention studies appear to show marked benefits from supplementation with antioxidants, particularly with vitamin E, but there are also disconcerting reports that supplements can have adverse effects in certain population groups. This is particularly the case for P-carotene which has increased mortality rates in at least 2 studies. Consequently, the role of antioxidants in the prevention or cure of vascular disease is still problematical although there is now increasing awareness that there is a distinction between the amounts required to avoid overt deficiency and those needed to promote optimum health. For example, estimated dietary vitamin E intakes for the UK population range from mg/person/day whereas they appear to be mg/day in Spain, where the incidence of vascular disease is lower 24. This latter range may be an important benchmark for setting nutritional requirements for optimum health. Although larger amounts may be therapeutically appropriate in certain circumstances and for particular risk groups, very high doses may induce adverse effects through pro-oxidant mechanisms 40. Therefore, increasing consumption of foods rich in antioxidants such as fresh fruit and vegetable is possibly more suitable for the UK population. Having said that, one of the authors (GGD) having experienced a mild cardiovascular event in his early forties now takes 90 mg vitamin E every second day in addition to the prescribed 75 mg aspirin and 40 mg simvastatin each day. Acknowledgement The authors are grateful for financial support from the Scottish Office Agriculture, Environment and Fisheries Department (SOAEFD). British Medical Bulletin 1999;55 (No. 3) 575
9 Micronutrients in health and disease References 1 Ness AR, Powles JW. Fruit and vegetables, and cardiovascular disease: a review. Int] Epidemiol 1997; 26: Slater TF. Free-radical mechanisms in tissue injury. Biochem } 1984; 222: Diplock AT. Antioxidants and disease prevention. Mol Aspects Med 1994; 15: Krinsky Nl Mechanism of action of biological antioxidants. Proc Soc Exp Biol Med 1992; 200: Scott G. Antioxidants in Science, Technology, Medicine and nutrition. Chichester: Albion, Steinberg D. Low density lipoprotein and its pathological significance. / Biol Chem 1997; 272: Westhuyzen J. The oxidation hypothesis of atherosclerosis: an update. Ann Clin Lab Set 1997; 27: Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerotic heart disease. New Engl J Med 1997; 337: Pratico D, luliano L, Mauriello A et al. Localisation of distinct F2-isoprostanes in human atherosclerotic lesions. / Clin Invest 1997; 100: Yla-Herttuala S, Palinski W, Rosenfield ME et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. / Clin Invest 1989; 84: Holvoet P, Collen D. Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis. Atherosclerosis 1998; 137: S Holvoet P, Perez G, Zhao Z et al. Malonaldehyde-modified low density lipoproteins in patients with atherosclerotic disease. / Clin Invest 1995; 95: Aviram M, Fuhram B. Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis. Atherosclerosis 1998; 137: S Cynshi O, Kawabe Y, Suzuki T et al. Antiatherogenic effects of the antioxidant BO-653 in three different animal models. Proc Natl Acad Set USA 1998; 95: Williams RJ, Motteram JM, Sharp CH et al. Dietary vitamin E and the attenuation of early lesion development in modified Wartanabe rabbits. Atherosclerosis 1992; 94: Heller FR, Descamps O, Hondekjikn J-C. LDL oxidation: therapeutic perspectives. Atherosclerosis 1998; 137: Stephens NG, Parsons A, Schofield PM et al. Randomised control trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: Rapola J, Virtamo J, Ripatti S et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997; 349: Omenn GS, Goodman GE, Thornquist MD et al. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl] Med 1996; 334: Hennekens CH, Buring JE, Manson JE et al. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl ] Med 1996; 334: Stampler MJ, Hennekens MD, Marson JE et al. Vitamin E consumption and risk of coronary heart disease in women. N Engl] Med 1993; 328: Rimm EB, Stampler MJ, Ascherio A et al. Vitamin E consumption and risk of coronary heart disease in men. N Engl J Med 1993; 328: Kushi LH, Folsom AR, Prineas RJ et al. Dietary antioxidant vitamins and death from coronary heart disease. N Engl} Med 1996; 334: Bellizzi MC, Franklin MF, Duthie GG, James WPT. Vitamin E and coronary heart disease: the European paradox. Eur J Clin Nutr 1994; 48: Hertog MGL, Kromhout D, Aravanis C et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 1995; 155: Riemersma RA, Oliver M, Elton RA et al. Plasma antioxidants and coronary heart disease: vitamins C and E and selenium. Eur] Clin Nutr 1990; 44: British Medical Bulletin 1999,55 (No. 3)
10 Antioxidants and vascular disease 27 Gey KE On the antioxidant hypothesis with regard to arteriosclerosis. Bibl Nutr Dieta 1987: 37; Hertog MGL, Feskens EJ, Hollman PC et al. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly. Lancet 1993; 342: Knekt P, Reunanen A, Jarvinen R et al. Antioxidant vitamin intake and coronary mortality in a longitudinal study. Am J Epidemiol 1994; 139: Hertog MGL, Sweetman PM, Fehily AM et al. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly study. Am J Clm Nutr 1997; 65: Knekt P, Reunanen A, Jarvinen R et al. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994; 139: Losonscy KG, Harris TB, Havhk RJ. Vitamin E and vitamin C supplement use and the risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am} Clin Nutr 1996; 64: Evans RW, Shaten BJ, Day BW et al. Prospective association between lipid soluble antioxidants and coronary heart disease in men - The Multiple Risk Factor Intervention Trial. Am J Epidemiol 1998; 147: Hense HW, Stender M, Bors W et al. Lack of association between serum vitamin E and myocardial infarction in a population with high vitamin E levels. Atherosclerosis 1993; 103: Salonen JT, Salonen R, Pentilla I et al. Serum fatty acids, apoproteins, selenium and vitamin antioxidants and risk of death from coronary artery disease. Am J Cardiol 1985; 56: Duthie GG, Beattie JAG, Arthur JR et al. Blood antioxidants and indices of lipid peroxidation in subjects with angina pectoris. Nutrition 1994; 10: Kardinaal AFM, Kik FJ, Ringstaad J et al. Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC study. Lancet 1993; 342: Sklodowska M, Wasowicz W, Gromadzinska J et al. Selenium and vitamin E concentrations in plasma and erythrocytes of angina pectoris patients. Trace Elem Med 1991; 8: Riemersma RA, Wood DA, Macintyre CCA et al. Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene. Lancet 1991; 337: Brown KM, Morrice PC, Duthie GG. Erythrocyte vitamin E and plasma ascorbate concentrations in relation to erythrocyte peroxidation in smokers and non-smokers: dose response of vitamin E supplementation. Am J Clin Nutr 1997; 65: Meyer F, Bairati I, Dagenais GR. Lower ischemic heart disease incidence and mortality among vitamin supplement users. Can } Cardiol 1996; 12: Daviglus ML, Orencia AJ, Dyer AR et al. Dietary vitamin C, beta-carotene and 30-year risk of stroke: results from the Western Electric study. Neuroepidemiology 1997; 16: British Medical Bulletin 1999;55 (No. 3) 577
Vitamin E and heart disease: a case study 1,2
Vitamin E and heart disease: a case study 1,2 Lawrence H Kushi ABSTRACT The role of nutritional epidemiology studies in the development of nutritional recommendations has been controversial, in part because
More informationUCLA Nutrition Noteworthy
UCLA Nutrition Noteworthy Title Vitamin C and the Risk of Coronary Heart Disease Permalink https://escholarship.org/uc/item/5xg9t04z Journal Nutrition Noteworthy, 4(1) ISSN 1556-1895 Author Chang, Angela
More informationThe oxidative modification hypothesis of coronary heart
Plasma Carotenoids and Tocopherols and Risk of Myocardial Infarction in a Low-Risk Population of US Male Physicians A. Elisabeth Hak, MD, PhD; Meir J. Stampfer, MD, DrPH; Hannia Campos, PhD; Howard D.
More informationTHERE is growing evidence that the oxidative modification
1156 THE NEW ENGLAND JOURNAL OF MEDICINE May 2, 1996 DIETARY ANTIOXIDANT VITAMINS AND DEATH FROM CORONARY HEART DISEASE IN POSTMENOPAUSAL WOMEN LAWRENCE H. KUSHI, SC.D., AARON R. FOLSOM, M.D., RONALD J.
More informationAtherosclerotic cardiovascular disease (CVD) involving. Vitamin Supplementation and Cardiovascular Disease CLINICAL REVIEW. William T.
Vitamin Supplementation and Cardiovascular Disease William T. Donahoo, MD Abstract Objective: To review the evidence of the effectiveness of antioxidant vitamins for the prevention and treatment of cardiovascular
More informationAntloxidant vitamins in the prevention of cardiovascular disease
European Heart Journal (1997) 18, 719-727 Clinical Perspective Antloxidant vitamins in the prevention of cardiovascular disease The epidemiological evidence Introduction Recent evidence suggests that in
More informationAntioxidants in food, drinks and supplements for cardiovascular health
Position statement Antioxidants in food, drinks and supplements for cardiovascular health This position statement provides recommendations for the consumption of antioxidantrich food, drinks and supplements
More informationAntioxidant Products
Antioxidant Products Introduction Introduction Antioxidant Total Antioxidant Status (TAS) Ransel Ransod Glutathione Reductase Antioxidants help defend living organisms against free radical attack. Many
More informationFITEYE Tablets (Multivitamin + Minerals)
Published on: 10 Jul 2014 FITEYE Tablets (Multivitamin + Minerals) Each Tablet Contains Vitamin C Vitamin E Vitamin A (as beta carotene) Vitamin B2 Lutein Zeaxanthin Zinc Copper Selenium L-Glutathione
More informationBiologic Oxidation BIOMEDICAL IMPORTAN
Biologic Oxidation BIOMEDICAL IMPORTAN Chemically, oxidation is defined as the removal of electrons and reduction as the gain of electrons. Thus, oxidation is always accompanied by reduction of an electron
More informationnumber Done by Corrected by Doctor
number 19 Done by حسام ابو عوض Corrected by وسيم ابو عبيدة Doctor د.نايف 1 P a g e GAGs and Glycoproteins: GAGs: long, unbranched heteropolysaccharides, made from زunits repeating disaccharide [Acidic
More informationORIGINAL INVESTIGATION. Vitamin Supplement Use in a Low-Risk Population of US Male Physicians and Subsequent Cardiovascular Mortality
ORIGINAL INVESTIGATION Vitamin Supplement Use in a Low-Risk Population of US Male Physicians and Subsequent Cardiovascular Mortality Jorg Muntwyler, MD, MPH; Charles H. Hennekens, MD, DrPH; JoAnn E. Manson,
More informationThe New England Journal of Medicine VITAMIN E SUPPLEMENTATION AND CARDIOVASCULAR EVENTS IN HIGH-RISK PATIENTS
VITAMIN E SUPPLEMENTATION AND CARDIOVASCULAR EVENTS IN HIGH-RISK PATIENTS THE HEART OUTCOMES PREVENTION EVALUATION STUDY INVESTIGATORS* ABSTRACT Background Observational and experimental studies suggest
More informationColor Your Customers Healthy With Carotenoids
Color Your Customers Healthy With Carotenoids By Yousry Naguib, PhD Fruits and vegetables get their vibrant colors from carotenoids, a class of closely related chemicals. Approximately 600 carotenoids
More informationAntioxidants in health and disease
176 J Clin Pathol 2001;54:176 186 Antioxidants in health and disease Department of Clinical Biochemistry, Institute of Clinical Science, Grosvenor Road, Belfast, Northern Ireland, BT12 6BJ, UK I S Young
More informationVarious studies have evaluated the antioxidant effects of vitamin E in the prevention or
REVIEW ARTICLE Vitamin E and Coronary Artery Disease Anne P. Spencer, PharmD; Deborah Stier Carson, PharmD; Michael A. Crouch, PharmD Various studies have evaluated the antioxidant effects of vitamin E
More informationAntioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts 1 3
Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts 1 3 Paul Knekt, John Ritz, Mark A Pereira, Eilis J O Reilly, Katarina Augustsson, Gary E Fraser, Uri Goldbourt, Berit
More informationConsumption of fruits and vegetables has been shown to
Intake of Flavonoids, Carotenoids, Vitamins C and E, and Risk of Stroke in Male Smokers Tero Hirvonen, MSc; Jarmo Virtamo, MD; Pasi Korhonen, MSc; Demetrius Albanes, MD; Pirjo Pietinen, DSc Background
More informationFree Radicals in Biology and Medicine
Free Radicals in Biology and Medicine 0 \ Second Edition BARRY HALLIWELL Professor of Medical Biochemistry, University of London King's College and JOHN M.C. GUTTERIDGE Senior Scientist, National Institute
More informationVitamin K & Antioxidants. NUT1602 E-Tutor 2018
Vitamin K & Antioxidants NUT1602 E-Tutor 2018 Vitamin K O Can be obtained from non-food source O Bacteria in the GI tract O Acts primarily in blood clotting O Prothrombin O Metabolism of bone proteins
More informationLipid Oxidation and its Implications to Food Quality and Human Health. Dong Uk Ahn Animal Science Department Iowa State University
Lipid Oxidation and its Implications to Food Quality and Human Health Dong Uk Ahn Animal Science Department Iowa State University Introduction Process of Lipid Oxidation Free Radicals and Reactive Oxygen
More informationLifePak Health Benefits. LifePak is optimum supplementation for:
LifePak What is LifePak? Our comprehensive nutritional wellness program delivering the optimum amounts of all essential and generally beneficial nutrients for long-term health and well-being. LifePak Health
More informationTITLE PAGE EFFECT OF MONOUNSATURATED FAT IN THE DIET ON THE SERUM CAROTENOID LEVELS
TITLE PAGE EFFECT OF MONOUNSATURATED FAT IN THE DIET ON THE SERUM CAROTENOID LEVELS By KIRAN DEEP KAUR AHUJA Bachelors in Science (Nutrition), Diploma (Nutrition and Health Education) Graduate Diploma
More informationSaturated fat- how long can you go/how low should you go?
Saturated fat- how long can you go/how low should you go? Peter Clifton Baker IDI Heart and Diabetes Institute Page 1: Baker IDI Page 2: Baker IDI Page 3: Baker IDI FIGURE 1. Predicted changes ({Delta})
More informationReactive Oxygen species ROS + Anti-oxidants. Dr. Naif Karadsheh
Reactive Oxygen species ROS + Anti-oxidants Dr. Naif Karadsheh Oxygen Toxicity & Free Radicals Biradical O 2 Radical O 2 Non-Radical Radical H 2 O 2 OH ROS O 2 Metabolism and Toxicity O 2 Consumption >90%
More informationPart 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD
Week 3: Cardiovascular Disease Learning Outcomes: 1. Define the difference forms of CVD 2. Describe the various risk factors of CVD 3. Describe atherosclerosis and its stages 4. Describe the role of oxidation,
More informationAging and nutrition 03/11/2012. Why do people age? Oxidative stress and damage
Aging and nutrition % of elderly people in Canadian population is increasing more than for other age groups within the elderly age group there is great variability in terms health, metabolism, physical
More informationTHE SAME EFFECT WAS NOT FOUND WITH SPIRITS 3-5 DRINKS OF SPIRITS PER DAY WAS ASSOCIATED WITH INCREASED MORTALITY
ALCOHOL NEGATIVE CORRELATION BETWEEN 1-2 DRINKS PER DAY AND THE INCIDENCE OF CARDIOVASCULAR DISEASE SOME HAVE SHOWN THAT EVEN 3-4 DRINKS PER DAY CAN BE BENEFICIAL - WHILE OTHERS HAVE FOUND IT TO BE HARMFUL
More informationROLE OF ANTIOXIDANTS IN FEED AND EFFECTS ON MEAT QUALITY
ROLE OF ANTIOXIDANTS IN FEED AND EFFECTS ON MEAT QUALITY Sergi Carné*, Anna Zaragoza Technical Department Industrial Técnica Pecuaria, S.A. (ITPSA) *scarne@itpsa.com Rancidity is associated with the breakdown
More informationGlossary For TheFatNurse s For All Ages Series Adipocytes, also known as lipocytes and fat cells, are the cells that primarily compose adipose tissue, specialized in storing energy as fat. Apolipoprotein
More informationState of the art ingredients fast friendly service
ALPHA-LIPOIC ACID An Efficient Antioxidant α-lipoic acid also known as thioctic acid, plays an important role in metabolic processes. It functions as a co-factor for a number of key enzymes that help in
More informationImportant reactions of lipids
Taif University College of Medicine Preparatory Year Students Medical chemistry (2) Part II (Lipids) week 4 lectures 1435-36 Important reactions of lipids Lectures outlines Definition and importance of
More informationHeart Disease Genesis
Heart Disease Genesis The Ultimate Lecture on CAD origins Petr Polasek MD FRCPC FACC Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,
More informationKEY COMPONENTS. Metabolic Risk Cardiovascular Risk Vascular Inflammation Markers
CardioMetabolic Risk Poor blood sugar regulation and unhealthy triglyceride and lipoprotein levels often present long before the diagnosis of type 2 Diabetes. SpectraCell s CardioMetabolic and Pre-Diabetes
More information1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?
1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones? 3How are dietary lipids transported? 4How lipids synthesized in the liver are transported? 5 Lipoprotien
More informationThis student paper was written as an assignment in the graduate course
77:222 Spring 2005 Free Radicals in Biology and Medicine Page 0 This student paper was written as an assignment in the graduate course Free Radicals in Biology and Medicine (77:222, Spring 2005) offered
More informationA deficiency of biotin, commonly seen in alcoholics, can cause neurological symptoms
Water-soluble vitamins Vitamin deficiencies Metabolism General Diseases etc. A deficiency of biotin, commonly seen in alcoholics, can cause neurological symptoms Levels of folate are particularly low in
More informationThe role of antioxidant vitamins in the primary
SPRING 2003 PREVENTIVE CARDIOLOGY 85 Treatment of Atherosclerosis in the New Millennium: Is There a Role for Vitamin E? Emma A. Meagher, MD From the Center for Experimental Therapeutics and Department
More informationFruit and vegetable intake and risk of cardiovascular disease: the Women s Health Study 1,2
Fruit and vegetable intake and risk of cardiovascular disease: the Women s Health Study 1,2 Simin Liu, JoAnn E Manson, I-Min Lee, Stephen R Cole, Charles H Hennekens, Walter C Willett, and Julie E Buring
More informationLESSONS FROM THE RESULTS OF OBSERVATIONAL STUDIES AND TRIALS OF BETA-CAROTENE AND VITAMIN E?
LESSONS FROM THE RESULTS OF OBSERVATIONAL STUDIES AND TRIALS OF BETA-CAROTENE AND VITAMIN E? Julie E. Buring, ScD American College if Epidemiology Chicago, September 2003 BETA-CAROTENE AND CANCER At the
More informationHIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES
HIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES A study published in the British Medical Journal shows that not only is high LDL cholesterol not a risk factor for all-caused
More informationEffects of whole grain intake on weight changes, diabetes, and cardiovascular Disease
Effects of whole grain intake on weight changes, diabetes, and cardiovascular Disease Simin Liu, MD, ScD Professor of Epidemiology and Medicine Director, Center for Global Cardiometabolic Health Brown
More informationChest pain affects 20% to 40% of the general population during their lifetime.
Chest pain affects 20% to 40% of the general population during their lifetime. More than 5% of visits in the emergency department, and up to 40% of admissions are because of chest pain. Chest pain is a
More informationBIOASTIN Bioastin is product that contains 4 mg astaxantin and 50 i.e. vitamin E (α-tocopherol) per tabl.. Carotenoids are family of around 700 substa
INTRODUCTION In 1956 Rebecca Gerchman and Daniel Gilbert detected toxic effect of superoxid on aerobs. Till today there are identificated many free radicals. Their toxic effect is registrated in more than
More informationChemical and Biochemical Mechanism Of Cell Injury.
Chemical and Biochemical Mechanism Of Cell Injury. Professor Dr. M. Tariq Javed Dept. of Pathology Faculty of Vet. Science The University Of Agriculture Faisalabad Cell Injury When the cell is exposed
More informationDyslipidemia Endothelial dysfunction Free radicals Immunologic
ATHEROSCLEROSIS Hossein Mehrani Professor of Clinical Biochemistry Definition Atherosclerosis: Is a chronic inflammatory process characterized by plaque formation within the vessel wall of arteries and
More informationNutrition & Wellness for Life 2012 Chapter 6: Fats: A Concentrated Energy Source
Tools: Printer 8.5 x 11 paper Scissors Directions: 1. Print 2. Fold paper in half vertically 3. Cut along dashed lines Copyright Goodheart-Willcox Co., Inc. All rights reserved. Tissue in which the body
More informationThe Interaction of Cigarette Smoking and Antioxidants. Part I: Diet and Carotenoids
The Interaction of Cigarette Smoking and Antioxidants. Part I: Diet and Carotenoids Greg Kelly, ND Abstract It is logical that the requirement for antioxidant nutrients depends on a person s exposure to
More informationORIGINAL INVESTIGATION. Randomized Trials of Vitamin E in the Treatment and Prevention of Cardiovascular Disease
ORIGINAL INVESTIGATION Randomized s of Vitamin E in the Treatment and Prevention of Cardiovascular Disease Rachel S. Eidelman, MD; Danielle Hollar, PhD; Patricia R. Hebert, PhD; Gervasio A. Lamas, MD;
More informationQuestions and Answers About Beta Carotene Chemoprevention Trials
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Questions and Answers
More informationU.S Department of Agriculture. Agricultural Outlook Forum February 19 & 20, 2004 NUTRTIONAL STUDIES OF FUNCTIONAL FOODS
U.S Department of Agriculture Agricultural Outlook Forum 2004 February 19 & 20, 2004 NUTRTIONAL STUDIES OF FUNCTIONAL FOODS Joseph Spence Director Beltsville Human Nutrition Research Center Agricultural
More informationLipid/Lipoprotein Structure and Metabolism (Overview)
Lipid/Lipoprotein Structure and Metabolism (Overview) Philip Barter President, International Atherosclerosis Society Centre for Vascular Research University of New South Wales Sydney, Australia Disclosures
More informationPALM OLEIN BLENDING FOR TEMPERATE MARKET L/O/G/O
PALM OLEIN BLENDING FOR TEMPERATE MARKET L/O/G/O Basic Facts on Oil Palm Originated from West Africa, palm oil is the rich source of edible oil and has become important resource of vegetable oil in the
More informationAppendix 1 Characteristics of Trials Included in the Final Meta-Analysis (n = 50) [posted as supplied by author] Duration of Supplementa
Appendix 1 Characteristics of Trials Included in the Final Meta-Analysis (n = 50) [posted as supplied by author] Duration of Supplementa Participants tion, y (Average Age, y; (Follow-up Intervention vs.
More informationMetabolism of xenobiotics FM CHE 5-6
Metabolism of xenobiotics FM 3.5-10 CHE 5-6 Metabolism of xenobiotics Also called:! Biotransformation, or detoxification Primary metabolism secondary metabolism Goal: To make use of a compound or to facilitate
More informationnumber Done by Corrected by Doctor Nayef Karadsheh
number 17 Done by Abdulrahman Alhanbali Corrected by Lara Abdallat Doctor Nayef Karadsheh 1 P a g e Pentose Phosphate Pathway (PPP) Or Hexose Monophosphate Shunt In this lecture We will talk about the
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL A Meta-analysis of LDL-C, non-hdl-c, and apob as markers of cardiovascular risk. Slide # Contents 2 Table A1. List of candidate reports 8 Table A2. List of covariates/model adjustments
More informationORIGINAL IVESTIGATION. Tea Flavonoids May Protect Against Atherosclerosis
Tea Flavonoids May Protect Against Atherosclerosis The Rotterdam Study ORIGINAL IVESTIGATION Johanna M. Geleijnse, PhD; Lenore J. Launer, PhD; Albert Hofman, MD; Huibert A. P. Pols, MD; Jacqueline C. M.
More informationNutrients Involved in Antioxidant Function and Vision
CHAPTER 10 Nutrients Involved in Antioxidant Function and Vision Chapter Summary Antioxidants are compounds that protect cells and substances in the body from the damage caused by free radicals formed
More informationLujain Hamdan. Faisal Nimri
20 Lujain Hamdan Faisal Nimri...... Sources of NADPH [ The pentose phosphate pathway is the primary source of the NADPH and is the only source in RBC.] Cytosolic conversion of oxaloacetate to pyruvate
More informationSource Variation in Antioxidant Capacity of Cranberries from Eight U.S. Cultivars
33 Source Variation in Antioxidant Capacity of Cranberries from Eight U.S. Cultivars Peter J. Schaaf Faculty Sponsors: Margaret A. Maher and Ted Wilson, Departments of Biology/Microbiology ABSTRACT Antioxidants
More informationT H E B E T T E R H E A L T H N E W S
W H O L E H E A L T H A M E R I C A. C O M Dr. Paul G. Varnas & WholeHealthAmerica.com present J U L Y, 2 0 1 3 V O L U M E 1 0, I S S U E 7 T H E B E T T E R H E A L T H N E W S P R O T E C T F R O M
More informationSTROKE & DIETARY INFLUENCES ON COGNITION IN AGING
How Nutrition Changes the Aging Brain STROKE & DIETARY INFLUENCES ON COGNITION IN AGING Nafisa Jadavji, PhD nafisa.jadavji@carleton.ca REMINDER! Purpose of Course To present information about how nutrition
More information-Carotene affects antioxidant status in non-insulin-dependent diabetes mellitus
Pathophysiology 6 (1999) 157 161 www.elsevier.com/locate/pathophys -Carotene affects antioxidant status in non-insulin-dependent diabetes mellitus Yishai Levy *, Haya Zaltzberg, Ami Ben-Amotz, Yoram Kanter,
More informationStatus of LDL Oxidation and antioxidant potential of LDL in Type II Diabetes Mellitus
Biomedical Research 2010; 21 (4): 416-418 Status of LDL Oxidation and antioxidant potential of LDL in Type II Singh N, Singh N, Singh S K, Singh A K, Bhargava V. Department of Biochemistry, G. R. Medical
More informationMol Biotechnol Sep;37(1):31-7. Bioenergetic and antioxidant properties of coenzyme Q10: recent developments. Littarru GP, Tiano L.
Mol Biotechnol. 2007 Sep;37(1):31-7. Bioenergetic and antioxidant properties of coenzyme Q10: recent developments. Littarru GP, Tiano L. Source : Institute of Biochemistry, Polytechnic University of the
More informationregulates the opening of blood vessels, important for unhindered blood flow.
Vitamin E AT A GLANCE Introduction The term vitamin E describes a family of eight related, fat-soluble molecules. Among these, alphatocopherol has the highest biological activity and is the most abundant
More informationOxidative Stress, Oxidative Damage and Antioxidants A Beginners Guide
Oxidative Stress, Oxidative Damage and Antioxidants A Beginners Guide David J Marlin 1 and Catherine E Dunnett 2 David Marlin Consulting Ltd, Newmarket, Suffolk, UK 1 Independent Equine Nutrition Ltd,
More informationFuture directions for nutritional and therapeutic research in omega-3 3 lipids
Future directions for nutritional and therapeutic research in omega-3 3 lipids Philip Calder Professor of Nutritional Immunology University of Southampton Aim To review dietary sources and intakes of long
More informationVitamins, selenium, iron, and coronary heart disease risk in Indians, Malays, and Chinese in Singapore
J Epidemiol Community Health 1998;52:181 185 181 Department of Community, Occupational, and Family Medicine, National University of Singapore, Faculty of Medicine, Singapore 119260 Correspondence to: Associate
More informationFlavonoids and Cardiovascular Disease
Flavonoids and Cardiovascular Disease Julie Lovegrove Hugh Sinclair Professor of Human Nutrition University of Reading Micronutrients and Health APPG University of Reading 2014 www.reading.ac.uk Global
More informationDietary Reference Values: a Tool for Public Health
HOGE GEZONDHEISRAAD Dietary Reference Values: a Tool for Public Health CONSEIL SUPERIEUR DE LA SANTE Belgian Dietary Reference Values for Energy and Macronutrients: FATS G. De Backer Brussels, February
More informationThe levels of oxidative stress and antioxidants in diabetes mellitus before and after diabetic treatment with or without antioxidants
Original article: The levels of oxidative stress and antioxidants in diabetes mellitus before and after diabetic treatment with or without antioxidants *Sarita A Shinde, Anita D. Deshmukh, Adinath N. Suryakar,
More informationNutrition, Food, and Fitness. Chapter 6 Fats: A Concentrated Energy Source
Nutrition, Food, and Fitness Chapter 6 Fats: A Concentrated Energy Source Tools: Printer (color optional) 4 sheets of 8.5 x 11 paper Scissors Directions: 1. Print 2. Fold paper in half vertically 3. Cut
More informationMid Term Test- Template Questions
Mid Term Test- Template Questions Name : ID : Time: Date: Total points: 100 Instructions: 1. Only 20 questions from Section I and II, 10 questions from Section III will be counted for grading. 2. Try to
More informationQuestions 4/8/2016. Cholesterol overview. Cholesterol biological functions Component of biological membranes. Cholesterol chemistry
How much cholesterol can be part of a healthful diet? Dietary cholesterol: The good, the bad, and the egg? Are there specific foods that should be limited because of their cholesterol content? Sonia Vega-López,
More informationName of Policy: Measurement of Long-Chain Omega-3 Fatty Acids in Red Blood Cell Membranes as a Cardiac Risk Factor
Name of Policy: Measurement of Long-Chain Omega-3 Fatty Acids in Red Blood Cell Membranes as a Cardiac Risk Factor Policy #: 239 Latest Review Date: July 2010 Category: Laboratory Policy Grade: Active
More informationProtein Cleavage Due to Pro-oxidative Activity in Some Spices
Protein Cleavage Due to Pro-oxidative Activity in Some Spices Sittiwat Lertsiri Department of Biotechnology Faculty of Science, Mahidol University Phayathai, Bangkok 10400 Thailand Kanchana Dumri Department
More informationIN SEVERAL ARTICLES, NUTRIENTS IN
ORIGINAL CONTRIBUTION Fruit and Vegetable Intake in Relation to Risk of Ischemic Stroke Kaumudi J. Joshipura, ScD Alberto Ascherio, MD JoAnn E. Manson, MD Meir J. Stampfer, MD Eric B. Rimm, ScD Frank E.
More informationArteriosclerosis & Atherosclerosis
Arteriosclerosis & Atherosclerosis Arteriosclerosis = hardening of arteries = arterial wall thickening + loss of elasticity 3 types: -Arteriolosclerosis -Monckeberg medial sclerosis -Atherosclerosis Arteriosclerosis,
More informationConsiderable evidence supports the hypothesis
Relation of Consumption of Vitamin E, Vitamin C, and Carotenoids to Risk for Stroke among Men in the United States Alberto Ascherio, MD, DrPH; Eric B. Rimm, ScD; Miguel A. Hernán, MD, MPH; Edward Giovannucci,
More informationCAPROS CHOICE PRODUCT TO HELP IMPROVE CARDIOVASCULAR HEALTH PRODUCT OVERVIEW: CHEMISTRY:
APRS HIE PRDUT T HELP IMPRVE ARDIVASULAR HEALTH PRDUT VERVIEW: apros is a single ingredient derived from edible fruits having properties to support cardiovascular health by improving endothelial function
More informationUCLA Nutrition Bytes. Title. Permalink. Journal ISSN. Author. Publication Date. Vitamin C and Treating Coronary Artery Disease: More Hype than Hope?
UCLA Nutrition Bytes Title Vitamin C and Treating Coronary Artery Disease: More Hype than Hope? Permalink https://escholarship.org/uc/item/44m385rp Journal Nutrition Bytes, 14(1) ISSN 1548-601X Author
More informationBIOL 158: BIOLOGICAL CHEMISTRY II
BIOL 158: BIOLOGICAL CHEMISTRY II Lecture 5: Vitamins and Coenzymes Lecturer: Christopher Larbie, PhD Introduction Cofactors bind to the active site and assist in the reaction mechanism Apoenzyme is an
More informationEFFECT OF LYCOPENE IN TOMATO SOUP AND TOMATO JUICE ON THE LIPID PROFILE OF HYPERLIPIDEMIC SUBJECTS
EFFECT OF LYCOPENE IN TOMATO SOUP AND TOMATO JUICE ON THE LIPID PROFILE OF HYPERLIPIDEMIC SUBJECTS Nora Vigasini, Assistant Professor, Department of Home Science, Women s Christian College, Chennai, noravigas@gmail.com
More informationLIST OF ABBREVIATIONS
Diabetes & Endocrinology 2005 Royal College of Physicians of Edinburgh Diabetes and lipids 1 G Marshall, 2 M Fisher 1 Research Fellow, Department of Cardiology, Glasgow Royal Infirmary, Glasgow, Scotland,
More informationTypes of Free Radicals
Terminology Lipid Oxidation and Lipid peroxidation Free Radicals and Reactive oxygen species Fatty acyl group and methylene group Hydroperoxides and lipid peroxides Peroxyl radicals and alkoxyl radicals
More informationDiet, nutrition and cardio vascular diseases. By Dr. Mona Mortada
Diet, nutrition and cardio vascular diseases By Dr. Mona Mortada Contents Introduction Diet, Diet, physical activity and cardiovascular disease Fatty Fatty acids and dietary cholesterol Dietary Dietary
More informationThe Effect of Vitamin E Supplementation on Lipid Peroxidation in Patients with Endothelial Dysfunction
The Effect of Vitamin E Supplementation on Lipid Peroxidation in Patients with Endothelial Dysfunction Corina Zorila 1,Liana Mos 1, Elena Magopat 2, Eva Mera 3 1.Western University V. Goldis Arad, 2.Clinical
More informationVictor Tambunan. Department of Nutrition Faculty of Medicine Universitas Indonesia
Victor Tambunan Department of Nutrition Faculty of Medicine Universitas Indonesia 1 Handbook of Clinical Nutrition 4th ed., 2006, by D. C. Heimburger & J. A. Ard Krause s Nutrition & Diet Therapy 12th
More informationThe role of vitamin E (tocopherol) supplementation in the prevention
Review Article Schattauer 2011 579 The role of vitamin E (tocopherol) supplementation in the prevention of stroke A meta-analysis of 13 randomised controlled trials Qiong Bin; Xueying Hu; Yunfei Cao; Feng
More informationDRI Concept. DRI Concept
Risk of adverse effects 1.5 0 DRI Concept DRI Concept EAR RDA UL 1.5 0 Observed level intake Risk of inadequacy Tolerable Upper Intake Level The highest level of daily nutrient intake that is likely to
More informationFLAXSEED Health Benefits and Functionality. Kelley C. Fitzpatrick Director of Health FLAX COUNCIL OF CANADA
FLAXSEED Health Benefits and Functionality Kelley C. Fitzpatrick Director of Health FLAX COUNCIL OF CANADA Consumers are interested in Positive Nutrition The trend is no longer just to remove bad ingredients
More informationPathophysiology of Lipid Disorders
Pathophysiology of Lipid Disorders Henry Ginsberg, M.D. Division of Preventive Medicine and Nutrition CHD in the United States CHD is the single largest killer of men and women 12 million have history
More informationWeight Loss NOTES. [Diploma in Weight Loss]
Weight Loss NOTES [Diploma in Weight Loss] Fat s: The good, the bad and the ugly Fat s function in your body 1. Energy stores 2. Muscle fuel 3. Transportation 4. Cell membrane 5. Padding 6. Muscle fuel
More informationThe inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema
The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema Dept Cardiology, Leiden University Medical Center, Leiden,
More informationPaper No.: 01. Paper Title: FOOD CHEMISTRY. Module 25: Fat soluble vitamins: Properties, stability and. modes of degradation
Paper No.: 01 Paper Title: FOOD CHEMISTRY Module 25: Fat soluble vitamins: Properties, stability and modes of degradation CHAPTER 25 FAT SOLUBLE VITAMINS Properties, Stability & Modes of degradation Vitamins,
More informationThe health benefits of shellfish: What should we be promoting? Professor Bruce Griffin Nutrition Division Faculty of Health & Medical Sciences
The health benefits of shellfish: What should we be promoting? Professor Bruce Griffin Nutrition Division Faculty of Health & Medical Sciences What should we be promoting? Define health benefits in terms
More informationxidants and Myocardial Infarction the EURAMIC study
xidants and Myocardial Infarction the EURAMIC study IB'6 I Alwine F. M. Kardinaal f Antioxidants and Myocardial Infarction: the EURAMIC Study Alwine F.M. Kardinaal Promotoren : Dr.Ir. F.J. Kok Hoogleraar
More information